AzTrials
AzTrials

ViolenceNCT06455943

Evaluation of Thriving, Substance Use, Mental Health, and Repeat Injury Among Participants in the THRIVE Program

An observational study of Violence and Assault, run by Unity Health Toronto.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observational study is to determine the impact of a hospital-based violence intervention program on a person's capacity to thrive and recurrent intentional injury. The aims of this study are: 1. Read more about this study

Who is it for?
Ages 14 to 29 years
Conditions the study is for
Violence, Assault
How many people
90 participants
Where
No sites listed yet
Study dates
1 Jul 2024to 1 Jul 2035
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 to 29 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: Youth injured by interpersonal violence who present at the emergency department of Unity Health Toronto - St. Michael's Hospital will be offered the hospital-based violence intervention program called THRIVE. THRIVE case managers connect with youth and provide supports in-hospital and in the community following discharge, providing wrap-around care with a strengths-based approach.

Who may be able to join

  • ages 14-29
  • presentation with an injury due to violence (defined as a gun shot wound, stab wound, blunt or bodily force, inflicted by someone else)
  • participant in the THRIVE Program

Who cannot join

  • unable to consent due to language barrier or brain injury
  • sexual assault
  • child abuse
  • self-inflicted injury
  • residence >1 hour from Toronto city limits

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Jennifer Dekker, MSc contact

437-331-8644

jennifer.dekker@unityhealth.to

About this study

Official title: Evaluation of Thriving, Substance Use, Mental Health and Repeat Injury Among Participants in the THRIVE Program

The goal of this observational study is to determine the impact of a hospital-based violence intervention program on a person's capacity to thrive and recurrent intentional injury. The aims of this study are:

  1. To evaluate the impact of the HVIP on building personal capacity of youth who have experienced non-fatal violent injuries to thrive using:
Read more
  • Established measure changes in positive psychology and clinical metrics
  • A qualitative interview using thematic content analysis
  1. Plot the methodology proposed to measure the impact of THRIVE on subsequent injuries using administrative data sources

Participants will complete surveys, participate in a semi-structured interview, and have their rate of recurrent intentional injury tracked over time.

Researchers will compare the rates of intentional reinjury between participants in the THRIVE program and those who present at other hospitals with similar injuries to see if there is a difference in the rate of recurrent intentional injury a 1, 5, and 10 years.

Conditions
Violence, Assault

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To evaluate the impact of the HVIP on building personal capacity of youth who have experienced non-fatal violent injuries to thrive.

    To evaluate changes in thriving, substance use, and mental health, validated measures and qualitative measures will be used. Quantitative measures collected using validated instruments will provide objective measures of change over time; while context-specific and nuanced growth will be captured through a semi-structured interview.

    Measured: July 2024 - December 2025

  2. To pilot the methodology proposed to measure the impact of THRIVE on subsequent injuries within 1 year using administrative data sources

    After 1.5 years of enrolment in THRIVE, study participants will be deterministically linked. Linkage will provide a wealth of baseline characteristics (demographics, income/marginalization), injury characteristics (ICD-10 coding patterns which can be contrasted to THRIVE documentation), as well as the capacity to follow these linked patients administratively over time and identify subsequent ED presentations and admission across any hospital in Ontario.

    Measured: March - Sept 2026

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jun 2024
  2. Study start1 Jul 2024 (estimated)
  3. Primary completion1 Jul 2026 (estimated)
  4. Study completion1 Jul 2035 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06455943
Sponsor's protocol ID
THRIVE001
Status last verified
Jun 2024
First submitted
6 Jun 2024
Last updated
13 Jun 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Violence and Assault, run by Unity Health Toronto.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 13 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jennifer Dekker, MSc (437-331-8644, jennifer.dekker@unityhealth.to), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To evaluate the impact of the HVIP on building personal capacity of youth who have experienced non-fatal violent injuries to thrive. (time frame: July 2024 - December 2025). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jun 2024; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in